FDA Drug Approvals

HSA Drug Approvals

NEW HSA Drug Approvals Source: HSA (http://www.hsa.gov.sg, April – May 2016)

Active Ingredient:
Licence Holder:
Date of Approval:

OPDIVO CONCENTRATE FOR SOLUTION FOR INFUSION 10MG/ML Active Ingredient: Nivolumab

NEW HSA Drug Approvals Source: HSA (http://www.hsa.gov.sg, March 2016)

Active Ingredient:
Licence Holder:
Date of Approval:

diferent Tablets pills capsule heap mix isolated on white backgroundGANFORT PF EYE DROPS Active Ingredient: Bimatoprost, Timolol Licence Holder:

New HSA Drug Approvals

Active Ingredient:
Licence Holder:
Date of Approval:

Source: HSA (http://www.hsa.gov.sg, January-February 2015) ARTISS SOLUTION FOR SEALANT, DEEP

New HSA Drug Approvals

Active Ingredient:
Licence Holder:
Date of Approval:

New HSA Drug Approvals Source: HSA (http://www.hsa.gov.sg, December 2014)  

VIMPAT FILM-COATED TABLET 50MG

Active Ingredient:
Licence Holder:
Date of Approval:

Active Ingredient: Lacosamide Licence Holder: A. Menarini Singapore Pte. Ltd.
Copyright © 2013 All rights reserved. Content and images are meant for practicing medical doctors, allied health care professionals and other establishments in the medical industry. Reproduction or redistribution of any content and images, is prohibited without the prior written consent of Ezyhealth Media Pte Ltd.